Tumor-selective angiotensin blockers may improve response to cancer immunotherapy
A research team led by investigators at Massachusetts General Hospital (MGH) and the Massachusetts Institute of Technology (MIT) has found ...
A research team led by investigators at Massachusetts General Hospital (MGH) and the Massachusetts Institute of Technology (MIT) has found ...
Results from 10 years of follow-up Milan, Italy: Women with early, low risk, hormone-driven breast cancer are less likely to ...
The finding suggests immune cells could be targeted using existing therapiesCredit: Duke Health DURHAM, N.C. -- For many women who ...
Bottom Line: Six factors were associated with invasive recurrence of breast cancer after a diagnosis of ductal carcinoma in situ ...
Research in artificial intelligence by Case Western Reserve scientists give hope to patients of lung and breast cancer; new discoveries ...
Credit: Genomic Health WASHINGTON -- A new study suggests that Oncotype DX-guided treatment could reduce the cost for the first year ...
Credit: Photo by Fred Zwicky CHAMPAIGN, Ill. -- Treating breast tumors with two cancer drugs simultaneously may prevent endocrine resistance ...
Radioactive antibodies that target cancer cells are used for medical diagnostics with PET imaging or for targeted radioimmunotherapy. Researchers from ...
Lugano, Switzerland, 23 April 2019 - Innovative breast cancer treatment will be discussed during the first ESMO Breast Cancer Congress ...
Credit: National University of Singapore Cognitive impairment associated with cancer, also known as "chemobrain", has gained recognition as a complication ...
Exposing the impact of racism -- not just race -- on health outcomes Despite the growing body of evidence showing ...
Protein could be key to providing a precision medicine treatment to prevent the spread of cancer in people diagnosed with ...
Unexpected findings reveal relationship between the amino acid leucine and tamoxifen resistanceCredit: Photo Credit: BIDMC BOSTON - About one in ...
Study finds that resistant cells become vulnerable to MD Anderson-developed targeted therapyCredit: MD Anderson Cancer Center HOUSTON -- Researchers at ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.